Quest Diagnostics Inc vs Prospect Capital Corporation — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Prospect Capital Corporation trades at $2.27 (market cap $1.14B). The key difference: Quest Diagnostics Inc is far larger — about 23× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays the higher dividend (21.93%). Which is the better fit depends on your goals.
| DGX | PSEC | |
|---|---|---|
Market Cap | $26.21B | $1.14B |
Sector | Health | Financials |
52-Week High | $238.50 | $3.05 |
52-Week Low | $173.49 | $2.11 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.45% | 21.93% |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →